3,855 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Acquired by Brophy Wealth Management LLC

Brophy Wealth Management LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 3rd quarter, Holdings Channel.com reports. The fund bought 3,855 shares of the healthcare conglomerate’s stock, valued at approximately $2,254,000. UnitedHealth Group makes up approximately 0.8% of Brophy Wealth Management LLC’s holdings, making the stock its 23rd biggest holding.

Several other institutional investors also recently bought and sold shares of UNH. PineStone Asset Management Inc. grew its holdings in shares of UnitedHealth Group by 130.9% in the second quarter. PineStone Asset Management Inc. now owns 1,318,475 shares of the healthcare conglomerate’s stock valued at $671,447,000 after purchasing an additional 747,354 shares in the last quarter. QV Investors Inc. raised its position in shares of UnitedHealth Group by 33.8% during the 2nd quarter. QV Investors Inc. now owns 66,494 shares of the healthcare conglomerate’s stock valued at $33,863,000 after buying an additional 16,780 shares in the last quarter. ORG Partners LLC grew its position in UnitedHealth Group by 1,538.2% in the second quarter. ORG Partners LLC now owns 2,490 shares of the healthcare conglomerate’s stock worth $1,234,000 after acquiring an additional 2,338 shares in the last quarter. Addenda Capital Inc. raised its position in UnitedHealth Group by 2.8% during the second quarter. Addenda Capital Inc. now owns 25,599 shares of the healthcare conglomerate’s stock valued at $13,037,000 after purchasing an additional 696 shares during the period. Finally, Tsfg LLC boosted its holdings in shares of UnitedHealth Group by 10.6% in the 2nd quarter. Tsfg LLC now owns 386 shares of the healthcare conglomerate’s stock worth $197,000 after purchasing an additional 37 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 2.5 %

Shares of NYSE:UNH opened at $561.10 on Tuesday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $516.37 billion, a PE ratio of 36.55, a P/E/G ratio of 1.61 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The business’s fifty day simple moving average is $586.36 and its 200-day simple moving average is $559.39.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm posted $6.56 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.63 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.50%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analysts Set New Price Targets

Several research analysts have commented on UNH shares. UBS Group dropped their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Royal Bank of Canada reduced their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. KeyCorp assumed coverage on UnitedHealth Group in a research report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price for the company. TD Cowen boosted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Finally, Oppenheimer lifted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $626.84.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.